← Novo Nordisk
Episodes featuring Novo Nordisk
40 episodes, newest first.
- Oct 4, 2026
Cornell case exposes gaps between campus, police and prosecutorsTwo Ts In A Pod with Teddi Mellencamp and Tamra JudgeOct 4, 2026 - Oct 4, 2026
Experts challenge silence around sexual assault allegationsTwo Ts In A Pod with Teddi Mellencamp and Tamra JudgeOct 4, 2026 - Oct 3, 2026
Shannon Beador turns sorority politics into a leadership case studyTwo Ts In A Pod with Teddi Mellencamp and Tamra JudgeOct 3, 2026 - Oct 3, 2026
Seven Nobel contenders test the limits of prize recognitionFrom First PrinciplesOct 3, 2026 - Oct 2, 2026
Anthropic’s IPO exposes AI’s costly investor dilemmaRich Habits PodcastOct 2, 2026 - Oct 1, 2026
Cramer says Micron’s results matter more than its selloffMad Money w/ Jim CramerOct 1, 2026 - Sep 22, 2026
Alibaba’s AI push meets rallies in apparel and biotechStock MoversSep 22, 2026 - Sep 21, 2026
Novo Nordisk stumbles as SocGen promises easier profitsStock MoversSep 21, 2026 - Sep 21, 2026
Markets weigh Novo’s weak outlook and Greenland’s critical-metals stakesStock MoversSep 21, 2026 - Sep 21, 2026
Paramount settlement lifts media stocks as chips surgeStock MoversSep 21, 2026 - Sep 19, 2026
Frontier labs debate slowing AI as risks and rewards widenMoonshots with Peter DiamandisSep 19, 2026 - Sep 18, 2026
Enterprise AI stalls without organizational contextThe a16z ShowSep 18, 2026 - Sep 17, 2026
AI leaders debate whether safety requires slowing the frontierMoonshots with Peter DiamandisSep 17, 2026 - Sep 13, 2026
Biotech’s rally tests the promise of cancer breakthroughsWSJ's Take On the WeekSep 13, 2026 - Sep 12, 2026
Oil shock pushes markets toward higher ratesWSJ What’s NewsSep 12, 2026 - Sep 8, 2026
Drug setbacks hit Novartis as AI demand lifts ComputacenterStock MoversSep 8, 2026 - Sep 8, 2026
European stocks split between clinical risk and AI demandStock MoversSep 8, 2026 - Sep 8, 2026
Drug setback and cyberattack rattle major stock moversStock MoversSep 8, 2026 - Sep 8, 2026
Drug trial failure and cyberattack pressure major chipmakerStock MoversSep 8, 2026 - Sep 8, 2026
Drug trial setback rattles Amgen as Oracle and Bloom Energy riseStock MoversSep 8, 2026 - Sep 8, 2026
Stock gains meet clinical-trial risk and smarter-city planningStock MoversSep 8, 2026 - Sep 8, 2026
GE bets on vertical integration as corporate risks multiplyMotley Fool Hidden Gems InvestingSep 8, 2026 - Sep 8, 2026
AI’s math breakthrough meets a tougher test: real-world adoptionWSJ What’s NewsSep 8, 2026 - Sep 8, 2026
Canada’s tariffs test Trump’s trade strategyBloomberg Daybreak: US EditionSep 8, 2026